(Q45344178)

13 December 2017

Calcium-dependent release of adipocyte fatty acid binding protein from human adipocytes (English)

1 reference

13 December 2017

0 references

1 reference

4

S R Bornstein

1 reference

13 December 2017

I Schlottmann

1

1 reference

13 December 2017

M Ehrhart-Bornstein

series ordinal

2

1 reference

13 December 2017

M Wabitsch

series ordinal

3

1 reference

13 December 2017

V Lamounier-Zepter

series ordinal

5

1 reference

13 December 2017

language of work or name

English

0 references

publication date

19 December 2013

1 reference

International Journal of Obesity

13 December 2017

1 reference

13 December 2017

38

1 reference

13 December 2017

9

1 reference

13 December 2017

1221-1227

1 reference

https://scigraph.springernature.com/pub.10.1038/ijo.2013.241

13 December 2017

0 references

cites work

The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Improved glucose and lipid metabolism in genetically obese mice lacking aP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Metabolic and genetic predictors of circulating adipocyte fatty acid-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Brefeldin A: insights into the control of membrane traffic and organelle structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Comparative studies of intracellular transport of secretory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Pharmacology and toxicology of the monovalent carboxylic ionophores

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Mechanisms of regulated unconventional protein secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Continuous nucleocytoplasmic shuttling underlies transcriptional activation of PPARgamma by FABP4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Structural Basis for Activation of Fatty Acid-binding Protein 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Intracellular trafficking and secretion of adiponectin is dependent on GGA-coated vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Adiponectin and leptin are secreted through distinct trafficking pathways in adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Human adipocytes attenuate cardiomyocyte contraction: characterization of an adipocyte-derived negative inotropic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Fatty acid binding protein 4 predicts left ventricular mass and longitudinal function in overweight and obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones: a novel class of selective human A-FABP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

BMS309403 directly suppresses cardiac contractile function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease

21 January 2018

1 reference

12 December 2020

Adipocyte fatty acid-binding protein is released from adipocytes by a non-conventional mechanism

1 reference

12 December 2020

Adipocyte-derived factors suppress heart contraction

1 reference

12 December 2020

The effect of ionomycin on calcium fluxes in sarcoplasmic reticulum vesicles and liposomes

1 reference

12 December 2020

Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice

1 reference

12 December 2020

Improved Glucose and Lipid Metabolism in Genetically Obese Mice Lacking aP2

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2013.241

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/IJO.2013.241

1 reference

Dimensions Publication ID

13 December 2017

0 references

1 reference